COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 2783: Articles 27821-27830  | Next

Validation of the Kuwait Progression Indicator Score for predicting progression of severity in COVID19
Al Youha, S., Doi, S. A., Jamal, M. H., Almazeedi, S., Al Haddad, M., AlSeaidan, M., Al-Muhaini, A. Y., Al-Ghimlas, F., Al-Sabah, S. K.
10.1101/2020.05.21.20108639 — Posted: 2020-05-23
Effective Screening of SARS-CoV-2 Neutralizing Antibodies in Patient Serum using Lentivirus Particles Pseudotyped with SARS-CoV-2 Spike Glycoprotein
Tandon, R., Mitra, D., Sharma, P., Stray, S. J., Bates, J. T., Marshall, G. D.
10.1101/2020.05.21.20108951 — Posted: 2020-05-23
What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate, serial interval, and asymptomatic infection
Koh, W. C., Naing, L., Rosledzana, M. A., Alikhan, M. F., Chaw, L., Griffith, M., Pastore, R., Wong, J.
10.1101/2020.05.21.20108746 — Posted: 2020-05-23
Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review
Weiss, A., Jellingsoe, M., Sommer, M. O. A.
10.1101/2020.05.21.20108605 — Posted: 2020-05-23
The estimations of the COVID-19 incubation period: a systematic review of the literature
Zaki, N., Mohamed, E. A.
10.1101/2020.05.20.20108340 — Posted: 2020-05-23
Immunity after COVID-19: protection or sensitization ?
Danchin, A., TURINICI, G.
10.1101/2020.05.21.20108860 — Posted: 2020-05-23
Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens
Bravi, F., Flacco, M. E., Carradori, T., Volta, C. A., Cosenza, G., De Togni, A., Acuti Martellucci, C., Parruti, G., Mantovani, L., Manzoli, L.
10.1101/2020.05.21.20109082 — Posted: 2020-05-23
Development and clinical application of a rapid and sensitive loop-mediated isothermalamplification test for SARS-CoV-2 infection
Hu, X., Deng, Q., Li, J., Chen, J., Wang, Z., Fang, Z., Li, H., Zhao, Y., Yu, P., Li, W., Wang, X., Li, S., Zhang, L., Hou, T.
10.1101/2020.05.20.20108530 — Posted: 2020-05-23
Hospital admissions in inflammatory rheumatic diseases during the COVID-19 pandemic: incidence and role of disease modifying agents
Fernandez-Gutierrez, B., Leon, L., Madrid, A., Rodriguez-Rodriguez, L., Freites, D., Font, J., Mucientes, A., Colomer, J. I., Jover, J. A., Abasolo, L.
10.1101/2020.05.21.20108696 — Posted: 2020-05-23
Psychological Impact of COVID-19 on Pakistani University Students and How They Are Coping
Salman, M., Asif, N., Mustafa, Z. U., Khan, T. M., Shehzadi, N., Hussain, K., Tahir, H., Raza, M. H., Khan, M. T.
10.1101/2020.05.21.20108647 — Posted: 2020-05-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).